Cargando…

Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey

Type 1 diabetes mellitus (T1DM) complications corelate with C-peptide levels. However, the C-Peptide role has not been explored in resource limited countries. This study explored the relationship between C-peptide and complications. A cross-sectional study involving participants aged 0 to 25 years w...

Descripción completa

Detalles Bibliográficos
Autores principales: Majaliwa, Edna Siima, Muze, Kandi Catherine, Ndayongeje, Joel, Mfinanga, Sayoki Geofrey, Mmbaga, Blandina Theophil, Ramaiya, Kaushik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026112/
https://www.ncbi.nlm.nih.gov/pubmed/36950323
http://dx.doi.org/10.1177/2333794X231159790
_version_ 1784909474595602432
author Majaliwa, Edna Siima
Muze, Kandi Catherine
Ndayongeje, Joel
Mfinanga, Sayoki Geofrey
Mmbaga, Blandina Theophil
Ramaiya, Kaushik
author_facet Majaliwa, Edna Siima
Muze, Kandi Catherine
Ndayongeje, Joel
Mfinanga, Sayoki Geofrey
Mmbaga, Blandina Theophil
Ramaiya, Kaushik
author_sort Majaliwa, Edna Siima
collection PubMed
description Type 1 diabetes mellitus (T1DM) complications corelate with C-peptide levels. However, the C-Peptide role has not been explored in resource limited countries. This study explored the relationship between C-peptide and complications. A cross-sectional study involving participants aged 0 to 25 years with T1DM in Dar es salaam Tanzania, between 2021 and 2022 was done. Diabetes nephropathy and retinopathy were assessed. About 281 (92.4%) participants were screened, 144 (51.2%) were females. Mean age was 19 ± 6 years. Majority 175 (62.3%) had poor glycemic control (HbA1c) > 10%, and low C-Peptide level 201 (71.5%). Retinopathy was 11.7% and risk for nephropathy was 41.3%. About 13.4% and 41.8% with low C peptide had Retinopathy and high-risk nephropathy respectively. Age at diagnosis, poor glycemic control, low c peptide and duration of diabetes were associated with complications. Further prospective studies are needed to capture when complications set in, so to have better strategies to prevent complications.
format Online
Article
Text
id pubmed-10026112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-100261122023-03-21 Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey Majaliwa, Edna Siima Muze, Kandi Catherine Ndayongeje, Joel Mfinanga, Sayoki Geofrey Mmbaga, Blandina Theophil Ramaiya, Kaushik Glob Pediatr Health Original Research Article Type 1 diabetes mellitus (T1DM) complications corelate with C-peptide levels. However, the C-Peptide role has not been explored in resource limited countries. This study explored the relationship between C-peptide and complications. A cross-sectional study involving participants aged 0 to 25 years with T1DM in Dar es salaam Tanzania, between 2021 and 2022 was done. Diabetes nephropathy and retinopathy were assessed. About 281 (92.4%) participants were screened, 144 (51.2%) were females. Mean age was 19 ± 6 years. Majority 175 (62.3%) had poor glycemic control (HbA1c) > 10%, and low C-Peptide level 201 (71.5%). Retinopathy was 11.7% and risk for nephropathy was 41.3%. About 13.4% and 41.8% with low C peptide had Retinopathy and high-risk nephropathy respectively. Age at diagnosis, poor glycemic control, low c peptide and duration of diabetes were associated with complications. Further prospective studies are needed to capture when complications set in, so to have better strategies to prevent complications. SAGE Publications 2023-03-18 /pmc/articles/PMC10026112/ /pubmed/36950323 http://dx.doi.org/10.1177/2333794X231159790 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Majaliwa, Edna Siima
Muze, Kandi Catherine
Ndayongeje, Joel
Mfinanga, Sayoki Geofrey
Mmbaga, Blandina Theophil
Ramaiya, Kaushik
Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey
title Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey
title_full Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey
title_fullStr Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey
title_full_unstemmed Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey
title_short Correlation of C-Peptide With Complications Observed in Children and Adolescents With Type 1 Diabetes in Tanzania: A Cross-Sectional Survey
title_sort correlation of c-peptide with complications observed in children and adolescents with type 1 diabetes in tanzania: a cross-sectional survey
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026112/
https://www.ncbi.nlm.nih.gov/pubmed/36950323
http://dx.doi.org/10.1177/2333794X231159790
work_keys_str_mv AT majaliwaednasiima correlationofcpeptidewithcomplicationsobservedinchildrenandadolescentswithtype1diabetesintanzaniaacrosssectionalsurvey
AT muzekandicatherine correlationofcpeptidewithcomplicationsobservedinchildrenandadolescentswithtype1diabetesintanzaniaacrosssectionalsurvey
AT ndayongejejoel correlationofcpeptidewithcomplicationsobservedinchildrenandadolescentswithtype1diabetesintanzaniaacrosssectionalsurvey
AT mfinangasayokigeofrey correlationofcpeptidewithcomplicationsobservedinchildrenandadolescentswithtype1diabetesintanzaniaacrosssectionalsurvey
AT mmbagablandinatheophil correlationofcpeptidewithcomplicationsobservedinchildrenandadolescentswithtype1diabetesintanzaniaacrosssectionalsurvey
AT ramaiyakaushik correlationofcpeptidewithcomplicationsobservedinchildrenandadolescentswithtype1diabetesintanzaniaacrosssectionalsurvey